Orbis Allan Gray Ltd

Institutional investor · Portfolio as of Q2 2026

Q2 2026 biggest moves
  • BKNGBKNG

    Booking

    97× the shares

    now 4.4% of portfolio

  • INSMINSM

    Insmed

    3.2× the shares

    now 2.2% of portfolio

  • WLKWLK

    Westlake

    Cut 61%

    now 0.5% of portfolio

  • SHELSHEL

    Shell

    2.2× the shares

    now 2.4% of portfolio

95 changes in all

Top Holdings97 positions

Checking export access…
Activity:
CPAY

Corpay, Inc.

5.4M$1.8B6.2%$305.96+8.93%
10 qtrssince 2024-Q1
Increased
63
NBIS

Nebius Group N.V.

6.5M$1.8B6.2%——
23 qtrssince 2020-Q4
Decreased
0
BKNG

Booking Holdings Inc.

7.2M$1.3B4.4%$170.63+4.21%
13 qtrssince 2023-Q2
Increased
94
QXO

QXO, Inc.

74M$1.3B4.4%$15.77+9.58%
8 qtrssince 2024-Q3
Unchanged
0
BRKR

Bruker Corporation

17.9M$1.1B3.7%$35.84+67.75%
5 qtrssince 2025-Q2
Unchanged
0
RXO

RXO, Inc.

36.4M$1B3.5%$20.58+34.03%
15 qtrssince 2022-Q4
Unchanged
0
MSI

Motorola Solutions, Inc.

2.4M$992.4M3.4%$400.22+3.50%
25 qtrssince 2020-Q2
Increased
73
GOOGL

Alphabet Inc.

2.3M$836.5M2.9%$312.39+14.32%
3 qtrssince 2025-Q4
Decreased
0
EQT

EQT Corporation

15.7M$835.1M2.9%$58.49-9.66%
3 qtrssince 2025-Q4
Increased
69
XPO

XPO, Inc.

3.4M$698.6M2.4%——
30 qtrssince 2019-Q1
Decreased
0
SHEL
SHEL
ADR

Shell PLC

8.8M$686M2.4%$76.58-0.42%
18 qtrssince 2022-Q1
Increased
87
GXO

GXO Logistics, Inc.

13.4M$680.6M2.3%$58.55-13.41%
20 qtrssince 2021-Q3
Unchanged
0
ITUB
ITUB
Preferred

ITAU UNIBANCO HLDG S A

81.3M$664.2M2.3%$5.84+39.62%
6 qtrssince 2025-Q1
Increased
63
INSM

Insmed Incorporated

6.1M$647.9M2.2%$115.33-7.55%
5 qtrssince 2025-Q2
Increased
87
ALNY

Alnylam Pharmaceuticals, Inc.

2M$598.3M2.1%$281.29+7.02%
9 qtrssince 2024-Q2
Increased
74
FSV

FirstService Corporation

4M$574.7M2.0%$152.41-6.98%
12 qtrssince 2023-Q3
Increased
50
STE

STERIS plc

2.7M$563.8M1.9%$226.47-7.55%
6 qtrssince 2025-Q1
Increased
51
IBKR

Interactive Brokers Group, Inc.

6.1M$528.3M1.8%$17.99+383.41%
19 qtrssince 2021-Q4
Decreased
0
NEM

Newmont Corporation

5.5M$517.8M1.8%$56.83+64.01%
11 qtrssince 2023-Q4
Increased
53
PRAX

Praxis Precision Medicines, Inc.

1.5M$512.2M1.8%$308.25+8.61%
3 qtrssince 2025-Q4
Decreased
0
$29.1B
AUM
97
Positions
Q2 2026
Filing
HI rating · 3.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$17,483,397,547-5.93016135634%
2025-Q2$20,565,982,80417.6315001058%
2025-Q3$23,299,761,21913.2927195411%
2025-Q4$23,866,116,7572.43073537397%
2026-Q1$23,706,328,776-0.669518139993%
2026-Q2$29,098,622,77122.7462212557%
Activity profile
$ moved · Q2'26
New10%Increased52%Decreased35%Exited4%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 years
<1Q7%1-4Q24%1-2Y21%2Y+48%

Orbis Allan Gray Ltd manages $29.1B across 97 positions as of Q2 2026. Top holdings: CPAY (6.2%), NBIS (6.2%), BKNG (4.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3.5/5.0.

Top holdings by portfolio weight

Total AUM$29B
CPAY6.19%
NBIS6.16%
BKNG4.41%
QXO4.39%
BRKR3.71%
RXO3.45%
MSI3.41%
GOOGL2.87%
EQT2.87%
XPO2.40%
Other2.36%

Portfolio allocation by GICS sector

Sectors11
Healthcare16.82%
Industrials15.74%
Communication Services14.62%
Technology12.48%
Energy9.57%
Financial Services8.78%
Consumer Cyclical8.20%
Basic Materials6.47%
Consumer Defensive4.66%
Real Estate2.02%
Other0.63%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare, Industrials, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(3.5 / 5.0)
Holdings P&L52
Conviction63
Concentration59
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
FSVFSVFirstService Corporation
Q4 2024 → Q3 2026+3.8M shares+$458.7M
7Q
ENBENBEnbridge Inc
Q1 2025 → Q3 2026+4.2M shares+$195.6M
6Q
CPAYCPAYCorpay, Inc.
Q2 2025 → Q3 2026+1.7M shares+$803.3M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used